Marinova Pty Ltd   Overview Marinova specialises in the extraction and fractionation of fucoidans, sulphated polysaccharides found in marine macroalgae. The company has developed a library of fucoidan derivatives, and can isolate patentable fractions as active ingredients for pharmaceutical or medical device products. Marinova has developed FDA qualified analytical methods to characterise fucoidans, and is the only company to have successfully met FDA requirements for fucoidan use in pharmaceuticals. The company is ideally suited as a development partner for companies looking to develop natural polysaccharide-based pharmaceuticals. Marinova has a multi-industry focus, developing fucoidan extracts for pharmaceutical, nutraceutical and cosmetic applications. The company utilises a proprietary extraction process that does not require excessive heat or the use of solvents other than water. This prevents hydrolysation of the polysaccharides in extraction, and maintains purity and bioactivity. The company extracts fucoidans from a wide range of organic macroalgae, sourced from Tasmania, Patagonia and Nova Scotia. The company has a dedicated harvesting operation in Tasmania, and ensures all the macroalgae used is sourced in an environmentally sustainable manner. Business Opportunities (i.e Corporate Alliances/Partnerships) Relationships of interest: Manufacturing – Marinova seeks partnerships with companies with an interest in developing fucoidan APIs (Fucoidans are organic plant-sourced sulphated polysaccharides, often seen as bioequivalents to Heparin). Nutraceutical and cosmetic companies looking for novel active ingredients supported by published clinical trials.  Technology/Products and Services Description Isolation and characterisation of sulphated polysaccharide APIs derived from organic marine macroalgae. Provision of pure fucoidan materials for research assays. Qualified analysis of fucoidans to meet FDA medical device or pharmaceutical registration requirements. Provision of organic fucoidan extracts as active ingredients for nutraceuticals and cosmetics. Competitive Advantages We are the world’s only specialist fucoidan company. All our processing, from seaweed harvesting to manufacture of depyrogenated fucoidan derivatives, is ISO 9001 and under GMP conditions. We have already qualified FDA-acceptable analytical procedures to characterise our fucoidans for use as APIs. Our nutraceutical and cosmetic fucoidan extracts are organic, manufactured using a solvent-free process and supported by published clinical trials.    Website address: www.marinova.com.au